The Coronavirus pandemic–2022: Viruses, variants & vaccines

M Alexandridi, J Mazej, E Palermo, J Hiscott - Cytokine & growth factor …, 2022 - Elsevier
Since the beginning of the COVID-19 pandemic in 2019–2020, Cytokine & Growth Factor
Reviews has published several Special Issues focused on the biology, pathogenesis and …

Review on up-to-date status of candidate vaccines for COVID-19 disease

TM Belete - Infection and drug resistance, 2021 - Taylor & Francis
The global pandemic of COVID-19 caused by SARS-CoV-2 continues to spread and poses
serious threats to public health and economic stability throughout the world. Thus, to protect …

Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases

V Furer, C Rondaan, N Agmon-Levin, S Van Assen… - RMD open, 2021 - rmdopen.bmj.com
In view of the COVID-19 pandemic, there is an unmet clinical need for the guidelines on
vaccination of patients with autoimmune inflammatory rheumatic diseases (AIIRD). This …

An update review of globally reported SARS-CoV-2 vaccines in preclinical and clinical stages

H Motamedi, MM Ari, S Dashtbin, M Fathollahi… - International …, 2021 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of
the rapidly spreading pandemic COVID-19 in the world. As an effective therapeutic strategy …

[HTML][HTML] Blood pressure increase following COVID-19 vaccination: a systematic overview and meta-analysis

F Angeli, G Reboldi, M Trapasso, G Santilli… - Journal of …, 2022 - mdpi.com
Coronavirus disease 2019 (COVID-19) vaccines proved a strong clinical efficacy against
symptomatic or moderate/severe COVID-19 and are considered the most promising …

SARS-CoV-2 vaccines: Lights and shadows

F Angeli, A Spanevello, G Reboldi, D Visca… - European journal of …, 2021 - Elsevier
Vaccines to prevent acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection elicit
an immune neutralizing response. Some concerns have been raised regarding the safety of …

[HTML][HTML] Immunogenicity of candidate MERS-CoV DNA vaccines based on the spike protein

SS Al-Amri, AT Abbas, LA Siddiq, A Alghamdi… - Scientific reports, 2017 - nature.com
MERS-coronavirus is a novel zoonotic pathogen which spread rapidly to> 25 countries since
2012. Its apparent endemicity and the wide spread of its reservoir host (dromedary camels) …

[HTML][HTML] Headache worsening after COVID-19 vaccination: an online questionnaire-based study on 841 patients with migraine

M Silvestro, A Tessitore, I Orologio, P Sozio… - Journal of Clinical …, 2021 - mdpi.com
Vaccines have represented the breakthrough in the fight against COVID-19. Based on
reported headache attacks after vaccination in randomized controlled trials, we focused on …

Exploring the COVID-19 vaccine candidates against SARS-CoV-2 and its variants: where do we stand and where do we go?

G Joshi, P Borah, S Thakur, P Sharma… - Human Vaccines & …, 2021 - Taylor & Francis
ABSTRACT As of September 2021, 117 COVID-19 vaccines are in clinical development,
and 194 are in preclinical development as per the World Health Organization (WHO) …

[HTML][HTML] Polymeric nanoparticles and nanomicelles of hydroxychloroquine co-loaded with azithromycin potentiate anti-SARS-CoV-2 effect

AOS de Barros, SR Pinto, SRR Dos Reis… - Journal of Nanostructure …, 2023 - Springer
The outbreak of coronavirus (COVID-19) has put the world in an unprecedented scenario.
To reestablish the world routine as promote the effective treatment of this disease, the world …